Measurement Tool of Chemotherapy Sensitivity in Advanced Ovarian Cancer.
Where this comes from
- Record sourced from PubMed, PMID 32601078.
- Also identified by DOI 10.1158/1078-0432.CCR-20-1376.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The modeled Ca125 ELIMination rate constant K (KELIM) can be used as a measure of chemotherapy sensitivity in women with newly diagnosed advanced epithelial ovarian cancer who are being treated with neoadjuvant chemotherapy. This marker may aid in decision-making regarding surgical resection and alternate systemic treatments in this cohort.<i>See related article by You et al., p. 4625</i>.
Medical subject headings
- CA-125 Antigen
- Ovarian Neoplasms